Tokyo (JCN) Oct 14, 2005- PharmaDesign announced on October 11 that Mochida Pharmaceutical has signed a licensing agreement with Inpharmatica, a UK drug discovery firm, for Admensa Interactive, Inpharmatica’s proprietary in-silico suite of predictive drug absorption, distribution, metabolism and excretion (ADME) models and compound prioritization tools.
